Jianming Lu

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Venues

Cell death & disease

Endocrine-related cancer

International journal of nanomedicine

Genetic testing and molecular biomarkers

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjie Xie, Yixun Zhang, Qianfeng Xu, Guowei Zhong, Jundong Lin, Huichan He, Qiuling Du, Huijing Tan, Muqi Chen, Zhenjie Wu, Yulin Deng, Zhaodong Han, Jianming Lu, Jianheng Ye, Fen Zou, Yangjia Zhuo, Wei-De Zhong
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy. International journal of nanomedicine 19 (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Chao Cai, Qinwei Liu, Haoran Shan, Chuanfan Zhong, Guidong Chen, Zhouda Cai, Yu Zheng, Jianming Lu, Jiaojiao Tang, Zhuo-Yuan Lin
Aberrant Super-Enhancer Landscape in Enzalutamide-Resistant Prostate Cancer Cells. Genetic testing and molecular biomarkers (2024)
Chao Cai, Qinwei Liu, Haoran Shan, Chuanfan Zhong, Guidong Chen, Zhouda Cai, Yu Zheng, Jianming Lu, Jiaojiao Tang, Zhuo-Yuan Lin
Aberrant Super-Enhancer Landscape in Enzalutamide-Resistant Prostate Cancer Cells. Genetic testing and molecular biomarkers 28 (6) (2024)
Yihao Chen, Jiahong Chen, Yongcheng Shi, Xiaohui Ling, Shumin Fang, Chuanfan Zhong, Fengping Liu, Weide Zhong, Xuecheng Bi, Zhong Dong, Jianming Lu
Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma. Endocrine-related cancer 31 (3) (2024)
Wenjie Xie, Yixun Zhang, Qianfeng Xu, Guowei Zhong, Jundong Lin, Huichan He, Qiuling Du, Huijing Tan, Muqi Chen, Zhenjie Wu, Yulin Deng, Zhaodong Han, Jianming Lu, Jianheng Ye, Fen Zou, Yangjia Zhuo, Wei-De Zhong
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy. International journal of nanomedicine 19 (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Yihao Chen, Jiahong Chen, Yongcheng Shi, Xiaohui Ling, Shumin Fang, Chuanfan Zhong, Fengping Liu, Weide Zhong, Xuecheng Bi, Zhong Dong, Jianming Lu
Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma. Endocrine-related cancer 31 (3) (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Yihao Chen, Jiahong Chen, Yongcheng Shi, Xiaohui Ling, Shumin Fang, Chuanfan Zhong, Fengping Liu, Weide Zhong, Xuecheng Bi, Zhong Dong, Jianming Lu
Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma. Endocrine-related cancer 31 (3) (2024)
Yingke Liang, Wenjun Yin, Zhouda Cai, Hongwei Luo, Qinwei Liu, Chuanfan Zhong, Jiahong Chen, Zhuoyuan Lin, Yaqiang Huang, Zhenguo Liang, Junhong Deng, Weide Zhong, Chao Cai, Jianming Lu
N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer. Human genetics (2023)
Jianheng Ye, Shanghua Cai, Yuanfa Feng, Jinchuang Li, Zhiduan Cai, Yulin Deng, Ren Liu, Xuejin Zhu, Jianming Lu, Yangjia Zhuo, Yingke Liang, Jianjiang Xie, Yan-Qiong Zhang, Huichan He, Zhaodong Han, Zhenyu Jia, Weide Zhong
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal transduction and targeted therapy 8 (1) (2023)
Chuanfan Zhong, Kaihui Wu, Shuo Wang, Zining Long, Taowei Yang, Weibo Zhong, Xiao Tan, Zixian Wang, Chuanyin Li, Jianming Lu, Xiangming Mao
Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell death & disease 12 (8) (2021)
Chuanfan Zhong, Kaihui Wu, Shuo Wang, Zining Long, Taowei Yang, Weibo Zhong, Xiao Tan, Zixian Wang, Chuanyin Li, Jianming Lu, Xiangming Mao
Correction: Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell death & disease 12 (8) (2021)

Jianming Lu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jianming Lu